Smith: BioWave Raised About $6M Pre-Revenue from Angels and VC
Brad Smith · 1125 He's Sold $5m+ Of Magical Pad w/ 1,014 Needles Athletes Use to Kill Pain · Aug 23, 2018 · at 9:05
Brad Smith, founder of BioWave, describes the capital required to run clinical trials, achieve FDA clearance, and build production units prior to generating revenue.
0:00 / 0:05exact quote · 5.8s
720p mp4 · rendered on demand · StarZero watermark
“About six million I raised from both angel investors and a venture capital investor.”
quote is from the automated transcript, cleaned for reading: filler sounds and stutters are removed, nothing is rephrased. names can be misheard (the analysis reads context, assessments check outside sources). how →
More from Brad Smith
BioWave claims 30 of 32 NFL teams use its device
“Well, we have 30 or 32 NFL teams, so I could pick any team.”
BioWave gets 95% of clinic market revenue from disposable electrodes
“95% of the revenue in that market we're making from the sale of those percutaneous electrodes Even though we're selling the 3500 dollar device as well, that's much more of a disposable driven revenue stream.”
BioWave Charges $3,500 for Pro Unit and $895 for Home Device
“The pro unit is 3500 dollars, and our home prescription unit is 895 dollars.”
BioWave works with 24 NBA and 24 MLB teams
“So, but the, I would tell you the, in professional sports, and we have 24 NBA teams, 24 major league baseball teams, and other sports and whatnot, the NFL probably is our most profitable, because they have more players on a team”